ExploreWatchlistsPricing
  1. US-listed companies
  2. REGENEREX PHARMA, INC.
  3. Financials
  4. Return on Assets

REGENEREX PHARMA, INC. (RGPX)

Market cap
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Mar 31, 2025-249-72.84%
Mar 31, 2024-916.6-27.04%
Mar 31, 2023-1,256.4-17.16%
Mar 31, 2022-1,516.7-678.03%
Mar 31, 2021262.4+328.88%
Mar 31, 202061.2-60.55%
Mar 31, 2019155.1-99.64%
Nov 30, 201443,250.9-4761.96%
Nov 30, 2012-927.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat